Biz Expresso: Janta curfew, earnings to IPOs headlines Dalal Street is reading | Editorji
  1. home
  2. > business
  3. > Biz Expresso: Janta curfew, earnings to IPOs headlines Dalal Street is reading
prev iconnext button of playermute button of playermaximize icon
mute icontap to unmute
video play icon
00:00/00:00
prev iconplay paus iconnext iconmute iconmaximize icon
close_white icon

Biz Expresso: Janta curfew, earnings to IPOs headlines Dalal Street is reading

Apr 15, 2021 06:58 IST | By Editorji News Desk

As investors return after a midweek break here are the headlines that determine how the money moves -:

Covid Tracker: Sharp spike in numbers in Delhi with 17,282 new cases, UP joins into the surge with 20,510 new cases. While the economic heartland Maharashtra kicks off stricter restrictions from today reporting 58,952 fresh cases in the last 24 hours.

Vaccine Watch: The wait for foreign produced vaccines may be longer as long term commitments made by Pfizer, Moderna to US and EU would delay any scope of large scale imports by India in the near future.


Boardroom Buzz: Infosys reports earnings below expectations with constant currency growth of 2% and current year revenue guidance of 12-14% also seems conservative. Shareholders however will be pleased with the $1.2 billion share buyback at Rs 1750//share which is a 20% premium to Tuesday’s closing price.

Sector in Focus: Banks seek extension of recast scheme as Covid resurgence raises concerns on defaults. Reports indicate bankers met RBI to extend recast/moratorium scheme to retail and MSME loans. 

IPO Radar: Aditya Birla Sun Life AMC IPO plan gets a nod from Aditya Birla Capital as the board approves sale of 13.5% stake with Sun Life.

Business